The diagnostic accuracy of free DNA in combination with PPBP and PADI4 was higher than that of DNA alone and enabled us to identify 10% more NSCLC patients, the majority of whom had early stage disease. This evidence concerns the gene PADI4 and non-small cell lung carcinoma.